Effect of Silymarin as an Adjunct Therapy in Combination with Sofosbuvir and Ribavirin in Hepatitis C Patients: A Miniature Clinical Trial

Table 2

Effect of silymarin and SOF/RBV adjunct therapy on hematological parameters of selected HCV patients.

Parameters	Pretreatment		value	Posttreatment		value
	Control	Treated		Control	Treated
RBC (10^12/l)			0.386			0.335
WBC (10^9/l)			0.627			0.337
Hb (g/dl)			0.533			0.74
PCV (%)			0.672			0.005
MCV (fl)			0.673			0.01
MCH (pg)			0.022			0.001
MCHC (g/l)			0.248			0.991
Lymphocytes (%)			0.661			0.003
Monocytes (%)			0.166			0.695
Eosinophils (%)			0.526			0.008
Platelets (10^9/l)			0.467			0.123
Neutrophils (%)			0.642			0.401

Data values were expressed as the mean and standard deviation ().One-way ANOVA test was utilized for comparison between different groups. Values were statistically nonsignificant within the groups themselves (). CBC: complete blood count; RBC: red blood cells; Hb: hemoglobin; PCV: packed cell volume; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration.